This week we introduce new and emerging topics in the field. How are the topics introduced this week (technology, cultural humility, distance supervision) reflected in your training and in your evaluation? If not, how will you incorporate those topics? What are the ethical implications that may arise by incorporating or omitting this information?
Antidepressant MedicationsNameIndication, starting dose, target symptoms, and affected neurotransmittersHalf-life
Antidepressant Medications Name Indication, starting dose, target symptoms, and affected neurotransmitters Half-life (T1/2) CYP450 enzyme Notes/Notable side effects/Precautions SSRIs Citalopram (Celexa) Escitalopram (Lexapro) Fluoxetine (Prozac) Fluvoxamine (Luvox) Paroxetine (Paxil) Sertraline (Zoloft) SNRIs Venlafaxine (Effexor) Desvenlafaxine (Pristiq) Duloxetine (Cymbalta) Other Mirtazapine (Remeron) Trazadone (Desyrel) Vilazodone (Viibryd) Vortioxetine (Trintellix) Bupropion (Wellbutrin) This




